Long-course chemoradiation plus concurrent/sequential PD-1 blockade as neoadjuvant treatment for MMR-status-unscreened locally advanced rectal cancer: protocol of a multicentre, phase 2, randomised controlled trial (the POLAR-STAR trial).

BMJ open(2023)

引用 0|浏览10
暂无评分
摘要
NCT05245474.
更多
查看译文
关键词
advanced rectal cancer,rectal cancer,neoadjuvant treatment,long-course,mmr-status-unscreened,polar-star
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要